UiPath (PATH) CEO sells 45,000 shares at $15.7116 via 10b5-1

UiPath, Inc. (PATH) CEO and Chairman reported an insider sale under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

UiPath, Inc. (PATH) CEO and Chairman reported an insider sale under a Rule 10b5-1 trading plan. On 10/20/2025, the reporting person sold 45,000 shares of Class A common stock at a price reported as $15.7116, with the filing noting a transaction price range from $15.6300 to $15.8700.

After this transaction, the reporting person beneficially owned 29,828,585 shares directly, and an additional 240,000 shares indirectly through a spouse. The individual is listed as a Director, 10% Owner, and Officer (CEO and Chairman). The sale was executed pursuant to a qualified selling plan adopted under Rule 10b5-1.

Insider Trade Summary

Net Seller: 45,000 shares

Net Sell 2 txns

Insider Dines Daniel

Role CEO and Chairman

Sold 45,000 shs ($707K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	45,000	$15.7116	$707K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 29,828,585 shares (Direct); Class A Common Stock — 240,000 shares (Indirect, by Spouse)

Footnotes (2)

1. F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
2. F2. The range of prices for the transactions reported was from $15.6300 to $15.8700. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UiPath (PATH) disclose in this Form 4?

An insider sold 45,000 Class A shares on 10/20/2025 at a reported price of $15.7116 under a Rule 10b5-1 plan.

What price range did the UiPath (PATH) insider transactions cover?

The filing states a price range from $15.6300 to $15.8700 for the reported transactions.

How many UiPath (PATH) shares does the insider hold after the sale?

Following the sale, the insider beneficially owned 29,828,585 shares directly and 240,000 shares indirectly by spouse.

Was the UiPath (PATH) sale prearranged under Rule 10b5-1?

Yes. The filing states the shares were sold pursuant to a qualified selling plan under Rule 10b5-1.

What roles does the reporting person hold at UiPath (PATH)?

The reporting person is a Director, 10% Owner, and Officer (CEO and Chairman).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/20/2025 - 04:59 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/20/2025		S		45,000(1)	D	$15.7116(2)	29,828,585	D
Class A Common Stock								240,000	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $15.6300 to $15.8700. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	10/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.